weak ebitda miss larg sale
miss driven us sale declin qoq gnp high
exposur econdisk discount harmonis walgreen
ex-u trend weak india growth em
yoy cut ep tp
sale growth guidanc us busi
declin includ zetia ex-u part grow
model sale growth us declin
product welchol tacrolimu epiduo gel finacea
gnp achiev net debt reduct bn help wc
reduct view debt reduct conting
wc reduct capital-expenditure guidanc high mn
profit like similar well
stay neutral stock risk competit largest
product mupirocin weak us pipelin clear visibl
out-licens innov pipelin debt reduct stay weak
estimate pot chg tp
 chang prev ep
note glenmark pharmaceut presenc india us emerg market
compani also involv discoveri new molecul new chemic new
click detail financi
figur weak sale across region
quarter discount harmonis happen
walgreen econdisk ex-u also sale trend weak
india growth weak yoy adjust gst row growth
weak yoy
sale growth guidanc
gnp guid overal sale grow ex-
us busi grow us ex zetia grow yoy
estim build sale growth yoy us sale declin
report basi ex zetia sale increas yoy
support welchol market share alreadi
tacrolimu share alreadi approv epiduo gel
finacea almita velcad inject build taro enter
mupircoin cream per gnp guidanc
net debt reduct conting wc reduct
gnp reduc net debt bn help wc reduct
otherwis high capital-expenditure mn interest cost larg
nullifi oper cash flow expect similar situat
capital-expenditure still high mn case wc reduct
could net debt reduct well
takeaway confer call
gnp expect launch product us
alreadi launch welchol tacrolimu far
inr depreci benefit gnp mn everi
inr depreci usd
seretid gnp expect germani approv come
us plant commercialis gnp receiv
indor plant five observ
innov pipelin gnp go full blown ph trial
could take month complet
figur ebitda miss due weak sale
weak quarter ebitda miss
ebitda miss estim mainli due weak sale
trend across region particular us weak sale
declin qoq glenmark high exposur econdisk
seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid
report singl factor make invest decis
compani mention price
anubhav aggarw certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
price rate histori glenmark pharmaceut glen bo
signifi initi assumpt coverag
price rate histori wba oq
signifi initi assumpt coverag
decemb analyst stock rate defin follow
outperform stock total return expect outperform relev benchmark next month
neutral stock total return expect line relev benchmark next month
under-perform stock total return expect under-perform relev benchmark next month
relev benchmark region decemb japanes rate base stock total return rel analyst coverag univers
consist compani cover analyst within relev sector outperform repres attractiv neutral less attract
underperform least attract invest opportun octob canadian well european rate base stock total return
rel analyst coverag univers consist compani cover analyst within relev sector outperform repres
attract neutral less attract underperform least attract invest opportun latin american asia stock exclud japan
australia rate base stock total return rel averag total return relev countri region benchmark india bse sensex index
prior octob canadian rate base stock absolut total return potenti current share price rel
attract stock total return potenti within analyst coverag univers australian new zealand stoc ks expect total return calcul
includ roll dividend yield outperform rate assign greater equal under-perform less
equal neutral may assign overlap rate rang allow analyst assign rate put
context associ risk prior may rang outperform under-perform rate overlap ne utral threshold
oper juli
restrict certain circumst credit suiss polici and/or applic law regul preclud certain type commun
includ invest recommend cours credit suiss engag invest bank transact certain
rate nr credit suiss equiti research invest rate view stock secur relat compani
time
cover nc credit suiss equiti research provid on-going coverag compani offer invest rate invest view
equiti secur compani relat product
volatil indic stock defin volatil stock price move month least past
month analyst expect signific volatil go forward
analyst sector weight distinct analyst stock rate base analyst expect fundament and/or valuat
sector rel group histor fundament and/or valuat
overweight analyst expect sector fundament and/or valuat favor next month
market weight analyst expect sector fundament and/or valuat neutral next month
underweight analyst expect sector fundament and/or valuat cautiou next month
analyst coverag sector consist compani cover analyst within relev sector analyst may cover multipl sector
credit suiss distribut stock rate bank client
bank client
purpos nyse finra rate distribut disclosur requir stock rate outperform neutral under-perform close correspond
